Your browser doesn't support javascript.
loading
Erythromycin.
Brittain, D C.
Afiliação
  • Brittain DC; Health Science Center, State University of New York, Syracuse.
Med Clin North Am ; 71(6): 1147-54, 1987 Nov.
Article em En | MEDLINE | ID: mdl-3320616
Erythromycin is the only macrolide antibiotic to have gained widespread use in the United States. Introduced in 1952, it rapidly gained a popularity that it enjoys to this day. Numerous other antimicrobial agents have been marketed since that time: Whole new classes of antibiotics, both natural and synthetic, have been discovered, studied, and released for general use. Many of these newer agents boast a broader spectrum of antimicrobial activity, yet erythromycin's place in the clinician's arsenal is unthreatened because erythromycin remains the drug of first choice for a number of pathogens against which the new drugs are inactive. It is one of the safest antibiotics available for use today and when used against susceptible organisms and in indicated clinical situations, its effectiveness is unquestioned.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Infecções Bacterianas / Eritromicina Limite: Humans Idioma: En Ano de publicação: 1987 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Infecções Bacterianas / Eritromicina Limite: Humans Idioma: En Ano de publicação: 1987 Tipo de documento: Article